Șeful CNAS, despre lipsa citostaticelor: Sunt discontinuități, nu o problemă de finanțare a Casei

The president of the National Health Insurance House, Horațiu Moldovan, acknowledged supply disruptions for certain medications, including chemotherapy drugs, but attributed these issues to production and distribution chains rather than funding shortages. He emphasized the need to rethink the pricing and reimbursement system to avoid financial unsustainability. Moldovan highlighted that Romania's medication expenses have significantly increased, warning that without legislative changes, the country could face a budget crisis. He also criticized the current hospital funding model, advocating for a shift towards financing based on treated cases rather than bed availability.